Navigation Links
Milestone Scientific Announces Resignation of CEO
Date:3/18/2009

Chairman to Serve as Interim CEO until Executive Search for Replacement is Completed

Planned Investor Conference Call Rescheduled to Thursday, March 26, 2009 at 4:15 PM ET

LIVINGSTON, N.J., March 18 /PRNewswire-FirstCall/ -- Milestone Scientific Inc. (OTC Bulletin Board: MLSS), the recognized leader in advanced injection technologies, today announced that Leonard Osser, Chairman of the Board, will temporarily assume the post of Interim Chief Executive Officer upon the resignation of Joe Martin, effective March 27, 2009, as CEO and Director of the Company. Martin is leaving to pursue new career opportunities.

Yesterday, Milestone filed its Form 10K with the U.S. Securities & Exchange Commission for the year ended December 31, 2008.

Key financial highlights of the 2008 results compared to 2007 reflected:

  • Year-over-year revenue growth of 5%
  • Rise in gross profit margins, which increased to 60% from 55%
  • 19% decline in operating expenses
    • 13% reduction in sales, general and administrative costs
    • 58% decrease in research and development expenses
  • 60% reduction in net losses for the year
  • 56% decrease in product inventories
  • 55% decline in accounts payable
  • 70% reduction in net cash used in operating activities

The teleconference originally scheduled to begin tomorrow morning, March 19, 2009, at 11:00 AM ET has been rescheduled to Thursday, March 26, 2009, beginning at 4:15 PM ET. At that time, investors are encouraged to join management in a discussion regarding the financial results, changes in executive management and developments relating to its business and growth strategy. The rescheduled conference call can be accessed by dialing toll-free 1-800-366-7640. For those unable to participate at that time, a replay of the teleconference can be accessed domestically by dialing 1-800-405-2236 and enter the passcode 11127369#. The replay will be available for 90 days.

About Milestone Scientific Inc.

Headquartered in Livingston, New Jersey, Milestone Scientific is engaged in pioneering proprietary, highly innovative technological solutions for the medical and dental markets. Central to the Company's IP platform and product development strategy is its patented CompuFlo(R) technology for the improved and painless delivery of local anesthetic. Specifically, CompuFlo is a computer-controlled, pressure sensitive infusion, perfusion, suffusion and aspiration technology, which provides real-time readouts of pressures, fluid densities and flow rates, enabling the advanced delivery and removal of a wide array of fluids. The STA Single Tooth Anesthesia System(TM), a computer-controlled local anesthesia delivery system, uses this technology to provide dentists with audible and visual signals as to in-tissue pressure. Milestone's existing painless injection systems are currently sold in 25 countries. For more information on these and other innovative Milestone products, please visit the Company's web site found at www.milesci.com and www.STAis4U.com.

Safe Harbor Statement

This press release contains forward-looking statements regarding the timing and financial impact of the Milestone's ability to implement its business plan, expected revenues and future success. These statements involve a number of risks and uncertainties and are based on assumptions involving judgments with respect to future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond Milestone's control. Some of the important factors that could cause actual results to differ materially from those indicated by the forward-looking statements are general economic conditions, failure to achieve expected revenue growth, changes in our operating expenses, adverse patent rulings, FDA or legal developments, competitive pressures, changes in customer and market requirements and standards, and the risk factors detailed from time to time in Milestone's periodic filings with the Securities and Exchange Commission, including without limitation, Milestone's Annual Report on Form 10-KSB for the year ended December 31, 2007. The forward looking-statements in this press release are based upon management's reasonable belief as of the date hereof. Milestone undertakes no obligation to revise or update publicly any forward-looking statements for any reason.

    FOR MORE INFORMATION, PLEASE CONTACT:
    Elite Financial Communications Group
    Dodi Handy, President and CEO
    For Media Inquiries: Tiffany Korkis or Kathy Addison, Directors,
    Elite Media Group
    407-585-1080 or via email at mlss@efcg.net


'/>"/>
SOURCE Milestone Scientific Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Materials for Medical Devices Database Reaches Milestone
2. Reveille Software Reaches Customer Milestone and Expands Executive Team
3. Thermogenesis Technology Products Surpass Processing of More Than One Million Units of Cord Blood Stem Cells at 10-Year Milestone
4. Milestone Scientific to Exhibit at the Chicago Dental Societys 144th Midwinter Meeting
5. SOLX Announces 1000th Gold Shunt Implantation Milestone for Glaucoma Treatment
6. Medarex to Receive Milestone Payment from MedImmune for Allowance of an Investigational New Drug Application for MEDI-546
7. Mission Pharmacal Celebrates Historic Milestone
8. Turner Reaches Milestone on $323 Million Virtua West Jersey Replacement Hospital in Voorhees, N.J.
9. Concentric Medical Reaches Important Stroke Milestone
10. Hand Transplantation Marks Historical 10-Year Milestone
11. Prism Pharmaceuticals to Receive $10 Million Milestone Payment from Paul Capital Healthcare
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... , ... TopConsumerReviews.com recently awarded their highest five-star rating to Best Buy Eyeglasses, ... the United States and Canada wear eyeglasses. Once considered to be a purely functional ... a fashion statement. Even celebrities use glasses as a way of creating an iconic ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... Pixel Film ... Pro X. , "Film editors can give their videos a whole new perspective by ... Austin - CEO of Pixel Film Studios. , ProSlice Levels contains over 30 ...
(Date:6/26/2016)... Clarkston, Michigan (PRWEB) , ... June 26, 2016 ... ... respect to fertility once they have been diagnosed with endometriosis. These women need ... but they also require a comprehensive approach that can help for preservation of ...
(Date:6/25/2016)... ... ... of Bruton Memorial Library on June 21 due to a possible lice infestation, as reported ... head lice: the parasite’s ability to live away from a human host, and to infest ... in the event that lice have simply gotten out of control. , As lice are ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Medical Market Analysis 2016 - Forecast to 2022" report ... The report contains up to date financial data derived from ... of major trends with potential impact on the market during ... market segmentation which comprises of sub markets, regional and country ...
(Date:6/23/2016)... , June 23, 2016 Research and ... News Issue 52" report to their offering. ... influenza treatment creates a favourable commercial environment for MedImmune to ... patient base that will serve to drive considerable growth for ... would serve to cap sales considerably, but development is still ...
(Date:6/23/2016)... June 23, 2016 , , ... July 7, 2016 , , , , LOCATION: , , ... , , , EXPERT PANELISTS:  , , , Frost & ... Analyst, Christi Bird; Senior Industry Analyst, Divyaa Ravishankar and Unmesh Lal, ... The global pharmaceutical industry is witnessing an exceptional era. Several new ...
Breaking Medicine Technology: